Catherine Skari

How to Manage Thalassaemia During Pregnancy: Expert Advice from the BSH

A comprehensive multidisciplinary approach is essential for managing conception and pregnancy in patients with a variety of medical conditions, including…

Read More »

NEW APPROVAL | FDA Endorses Piasky for Paroxysmal Nocturnal Hemoglobinuria

Piasky, developed by Roche, is a monoclonal antibody that targets complement protein C5. Crovalimab binds to C5 to prevent its…

Read More »

Predicting Factors of Survival Rates Among α-and β-Thalassemia Patients: A Retrospective 10-Year Data Analysis

Background: Thalassemia is a genetic hemoglobinopathy in which a defective globin chain can cause transfusion-dependent anemia and other complications. As genotype…

Read More »

CAD | Enjaymo Not Cost-Effective at Current Price, According to US Study

This conclusion was drawn from a cost-effectiveness study utilizing data from the Phase 3 CARDINAL clinical trial, which backed the…

Read More »

SPOTLIGHT | TIF Wins Prestigious HemaSphere Award at EHA2024

The HemaSphere Awards were presented by the official journal of the European Hematology Association (EHA)  during Europe’s most important scientific…

Read More »

NEW PUBLICATION | Nutrition in Thalassaemia: A Guide for Patients, Families, and Caregivers

The guide encompasses: An overview of the nutritional needs specific to people with thalassaemia Methods for nutritional assessment Detailed explanations…

Read More »

WORLD BLOOD DONOR DAY 2024 | 20 Years of Celebrating Giving: Thank You Blood Donors!

Read More »

TIF STUDY | Patient and Caregiver Perceptions of Thalassaemia Care in 2023

The study revealed that most patients with thalassaemia are receiving adequate treatment, including regular blood transfusions, chelation therapy, proper monitoring,…

Read More »